Skip to content
Interagency Autism Coordinating Committee (IACC)
Autism Research Database
Office of Autism Research Coordination (OARC)
 

Question 4: Long-term Objective C

green dot 4LC. Conduct at least one study to evaluate the safety and effectiveness of medications commonly used in the treatment of co-occurring conditions or specific behavioral issues in people with ASD by 2015. IACC Recommended Budget: $10,000,000 over 5 years.

Projects Found: 8
Total Funding: 2834887
Project Title Funding Funding Institution

Project Title

Mirtazapine treatment of anxiety in children and adolescents with pervasive developmental disorders
$99,993

Funding

99993

Institution

Indiana University

Project Title

Targeted pharmacologic interventions for autism
$363,488

Funding

363488

Institution

Indiana University-Purdue University Indianapolis

Project Title

2/4-RUPP Autism Network: Guanfacine for the treatment of hyperactivity in PDD
$311,729

Funding

311729

Institution

Seattle Children's Hospital

Project Title

1/4-RUPP Autism Network: Guanfacine for the treatment of hyperactivity in PDD
$337,175

Funding

337175

Institution

Indiana University-Purdue University Indianapolis

Project Title

Pharmacotherapy of pervasive developmental disorders
$184,540

Funding

184540

Institution

Indiana University-Purdue University Indianapolis

Project Title

4/4-RUPP Autism Network: Guanfacine for the treatment of hyperactivity in PDD
$556,007

Funding

556007

Institution

Yale University

Project Title

3/4-RUPP Autism Network: Guanfacine for the treatment of hyperactivity in PDD
$393,205

Funding

393205

Institution

University of California, Los Angeles

Project Title

Metabolic signature of antipsychotics used in the treatment of autism
$588,750

Funding

588750

Institution

University of Cincinnati

 
Back to Top